Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, the Wall Street Journal reported on Wednesday, citing people familiar with ...
NYSE:MRK Earnings and Revenue History March 4th 2025 How Do Unusual Items Influence Profit? To properly understand Merck's profit results, we need to consider the US$4.2b expense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback